IP Library › Patent Application 14221662
Patent Application
App. No. 14/221,662

SIMPLE VACCINES FROM DNA LAUNCHED SUICIDAL FLAVIVIRUSES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/221,662
Abstract

Immunogenic compositions relating to DNA launched suicidal flaviviruses and methods of administering the same are described herein.

Claims (3)

1 . An immunogenic composition comprising:

(a) a first construct that comprises a nucleic acid sequence encoding a tick-borne encephalitis (TBE) core, Pre-M, and envelope proteins, but lacking the TBE non-structural replicon proteins; and

(b) a second construct that comprises a nucleic acid sequence encoding a hepatitis C virus (HCV) NS3/4A fusion protein and TBE non-structural replicon proteins.

Assignments (3)
SECURITY INTEREST Recorded Sep 29, 2015
From: TRIPEP AB
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 036714/0719 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2014
From: CHRONTECH PHARMA AB
To: TRIPEP AB
Reel/Frame 034521/0261 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2014
From: SALLBERG, MATTI; FRELIN, LARS; JOHANSSON, MAGNUS
To: CHRONTECH PHARMA AB
Reel/Frame 033965/0740 →